| Literature DB >> 24166907 |
Abstract
Glioblastoma is the most prevalent and malignant primary brain tumor in adults, and its response to current therapies is limited. Protein kinase CK2 is overexpressed in glioblastoma and regulates glioblastoma cell survival, proliferation, and migration and brain tumorigenesis. Targeting CK2 for glioblastoma treatment may benefit patients with glioblastoma. ©2013 AACR.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24166907 PMCID: PMC3932783 DOI: 10.1158/1078-0432.CCR-13-2478
Source DB: PubMed Journal: Clin Cancer Res ISSN: 1078-0432 Impact factor: 12.531